This post is also available in: 
Français
As China enters the Year of the Rat this Saturday (25 January), Jasmine Kang, Portfolio Manager at Comgest, the independent, international asset management group focused on quality growth investing, believes that China’s growth has become more sustainable but that high-quality companies
are still rare and strong stock selection is more important than ever in the Year of the Rat:
“The rat might be a shrewd and unpopular creature in our culture but in China it stands for diligence,
intelligence, energy, determination and achieving goals, so it is appropriate that it gives its name to a year in
which China’s growth model is becoming more sustainable and its equity markets more transparent and open
to foreign investors.
“At least economically the gods have been kind to the country in recent years. The shift in the Chinese
economy from credit and infrastructure-driven growth to innovation, services and consumer-oriented growth is
almost complete and real incomes are growing steadily. The opening of the Shenzhen and Shanghai stock
markets is proceeding at a rapid pace and China’s long-term potential as a financial centre is huge. Although
the share of foreign investors in Chinese A shares is still low, foreign institutional investors’ access to the
Shanghai and Shenzhen stock markets will continue to advance in the coming years, promoting capital
inflows and professionalising the capital market. The improvement of transparency and ESG issues is still in
its infancy, but more companies are already reporting in accordance with international standards.
“Despite the positive changes in the general environment, China remains a challenging place for stock
picking. High-quality companies still seem few and far between. In China it is particularly important for minority
shareholders to be in the same boat as the company’s decision-makers and managers. Governance
structures are of crucial importance for the success of long-term oriented quality growth investors. Investors
should have a diligent rat-like squint at potential investments to see if their growth is underpinned by strong
and open governance structures.
“Shandong Weigao Group Medical Polymer Co., Ltd is a prime example of how improvements in governance
structure favour minority shareholders. The company has long been a strong brand in the market for medical
consumables but its growth was below average for a long time. Equity investments were reserved for top
management only and were not tradeable. Through the reform of the Chinese capital market, these shares
have become tradeable and, thanks to employee participation programs, they have become an important
instrument for long-term corporate management and a catalyst for accelerating growth. Earnings per share
and the company share price have doubled over the past three years.
“Despite being known for its high volatility, in the long term, the outlook for the Chinese equity market is
positive. Over the past 12 months, the IT and healthcare-heavy ‘China Shenzhen’ index, with 36% value
growth in USD terms, has been one of the best stock markets in the world and has even outperformed the
Nasdaq. In the Year of the Rat, investors should keep a sense of proportion and not just chase after rising
prices, but rather invest in quality over the long term and be patient to achieve an optimal risk-return profile for
their Chinese investment.”
Add Comment